Spectral Medical Announces First Quarter Results and Provides Corporate Update
May 12, 2023 08:00 ET
|
Spectral Medical Inc.
New Trial Sites Enroll 60% of New Patient Enrollments Since the Beginning of April Tigris Patient Enrollment at 58 Patients TORONTO, May 12, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc....
Spectral Medical Inc. Announces Director Resignation
May 04, 2023 16:00 ET
|
Spectral Medical Inc.
TORONTO, May 04, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Announces Positive Results of EUPHAS-2 Clinical Trial Evaluating PMX in Critically Ill Endotoxemic Septic Shock Patients
April 18, 2023 08:00 ET
|
Spectral Medical Inc.
Reports 28-day mortality of just 36% for patients undergoing PMX hemoadsorption versus75% predicted by widely accepted SAPS II mortality estimation tool Results featured in premier peer-reviewed...
Spectral Medical Announces Investor Update Conference Call
April 06, 2023 08:00 ET
|
Spectral Medical Inc.
TORONTO, April 06, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...
Spectral Medical Announces Fourth Quarter and Fiscal 2022 Results and Provides Corporate Update
March 24, 2023 08:00 ET
|
Spectral Medical Inc.
Reports significant enhancements to accelerate Tigris patient enrollment including appointment of new Contract Research Organization Management to host Investor Day on April 6, 2023 TORONTO, March ...
Spectral Medical Announces the Opening of Two Additional Tigris Clinical Trial Sites
March 09, 2023 08:00 ET
|
Spectral Medical Inc.
TORONTO, March 09, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...
Spectral Medical Provides Update on Tigris Clinical Trial and Other Business Developments
January 12, 2023 07:30 ET
|
Spectral Medical Inc.
50 Patients Randomized to Date out of the 150 Total Target to be Enrolled Reports Significant Uptick in Screening and Enrollment Activities TORONTO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Spectral...
Spectral Medical Announces Strategic Joint Venture With Infomed to Accelerate Commercialization of Dimi and Sami Dialysis Devices
December 13, 2022 07:30 ET
|
Spectral Medical Inc.
TORONTO, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Announces Third Quarter Results and Provides Corporate Update
November 10, 2022 08:00 ET
|
Spectral Medical Inc.
TORONTO, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Inc. Closes $10.8 Million Public Offering and Concurrent Private Placement
November 02, 2022 09:29 ET
|
Spectral Medical Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (TSX: EDT) (“Spectral” or the...